SCHEMBL4427940

SCHEMBL4427940

CC(=O)C(c1ccc(F)cc1)(c1ccc(F)cc1)N1CCC(C(c2ccccc2)N2CCN(C)CC2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CACNA2D1 P54289 5/20 0.58
▸ CACNA1B Q00975 5/20 0.58
▸ CACNB1 Q02641 5/20 0.58
▸ CACNA1C Q13936 4/20 0.58
▸ CHRM3 P20309 4/20 0.41
▸ MC4R P32245 2/20 0.38
▸ MC1R Q01726 1/20 0.38
▸ OPRM1 P35372 2/20 0.36
▸ CHRM2 P08172 1/20 0.36
▸ CHRM4 P08173 1/20 0.36
▸ CHRM5 P08912 1/20 0.36
▸ ADRA2A P08913 1/20 0.36
▸ ADORA3 P0DMS8 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CHRM1 P11229 1/20 0.36
▸ DRD1 P21728 1/20 0.36
▸ ADRA1D P25100 1/20 0.36
▸ HTR2A P28223 1/20 0.36
▸ HTR2C P28335 1/20 0.36
▸ HRH1 P35367 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2791280 0.76 CACNA2D1 (0.66) CACNA2D1CACNA1BCACNB1CACNA1CCHRM3
SCHEMBL2797186 0.76 CACNA2D1 (0.92) CACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL2792554 0.75 CACNA2D1 (0.64) CACNA2D1CACNA1BCACNB1CACNA1CCHRM3
SCHEMBL3394375 0.73 CACNA2D1 (0.70) CACNA2D1CACNA1BCACNB1CACNA1CSLC6A3
SCHEMBL4279752 0.73 CACNA2D1 (0.66) CACNA2D1CACNA1BCACNB1CACNA1CCHRM3
SCHEMBL4279749 0.73 CACNA2D1 (0.66) CACNA2D1CACNA1BCACNB1CACNA1CCHRM3
SCHEMBL4426402 0.71 CACNA2D1 (0.51) CACNA2D1CACNA1BCACNB1CACNA1CCHRM3
SCHEMBL2793294 0.71 CACNA1B (0.74) CACNA2D1CACNA1BCACNB1CACNA1CMC4R
SCHEMBL27686363 0.70 CACNA2D1 (0.55) CACNA2D1CACNA1BCACNB1CACNA1CMC4R
SCHEMBL4279744 0.70 CACNA2D1 (0.77) CACNA2D1CACNA1BCACNB1CACNA1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2061780-A1 DIARYL PIPERIDINE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS Neuromed Pharmaceuticals, Ltd. (CA) 2009-05-27 — — EP claimed
WO-2008031227-A1 DIARYL PIPERIDINE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS NEUROMED PHARMACEUTICALS LTD. (CA) 2008-03-20 — — WO claimed
Send feedback